Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,666 | 628 | 99.2% |
| Education | $63.50 | 7 | 0.7% |
| Entertainment | $17.31 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,729 | 96 | $0 (2024) |
| ABBVIE INC. | $672.38 | 34 | $0 (2024) |
| Novo Nordisk Inc | $627.15 | 49 | $0 (2024) |
| PFIZER INC. | $582.08 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $564.67 | 46 | $0 (2024) |
| Lilly USA, LLC | $475.18 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $456.50 | 31 | $0 (2024) |
| Amgen Inc. | $413.33 | 27 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $336.56 | 29 | $0 (2020) |
| Corcept Therapeutics | $326.29 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,370 | 71 | AstraZeneca Pharmaceuticals LP ($459.64) |
| 2023 | $1,513 | 82 | ABBVIE INC. ($310.18) |
| 2022 | $868.56 | 48 | AstraZeneca Pharmaceuticals LP ($154.79) |
| 2021 | $1,299 | 75 | Supernus Pharmaceuticals, Inc. ($166.84) |
| 2020 | $1,117 | 76 | AstraZeneca Pharmaceuticals LP ($191.17) |
| 2019 | $1,169 | 90 | AstraZeneca Pharmaceuticals LP ($231.20) |
| 2018 | $1,382 | 115 | AstraZeneca Pharmaceuticals LP ($194.63) |
| 2017 | $1,029 | 79 | PFIZER INC. ($174.77) |
All Payment Transactions
636 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: UROLOGY | ||||||
| 09/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Endocrinology | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,072 | 1,561 | $116,952 | $42,485 |
| 2022 | 25 | 1,259 | 1,829 | $130,382 | $45,035 |
| 2021 | 16 | 1,062 | 1,424 | $110,561 | $45,418 |
| 2020 | 13 | 1,120 | 1,562 | $147,527 | $62,406 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 237 | $38,394 | $17,362 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $13,568 | $6,281 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 77 | $8,470 | $4,030 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 271 | $4,336 | $2,276 | 52.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,277 | $2,231 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 117 | 169 | $13,858 | $2,217 | 16.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 128 | 190 | $11,780 | $1,967 | 16.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 40 | $1,240 | $1,135 | 91.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 104 | 144 | $2,880 | $912.96 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 94 | $5,828 | $894.88 | 15.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 36 | 52 | $3,900 | $855.92 | 21.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 18 | $1,638 | $522.18 | 31.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 43 | 58 | $2,088 | $441.38 | 21.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 23 | 23 | $1,311 | $435.16 | 33.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 20 | 22 | $2,244 | $325.16 | 14.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 15 | $630.00 | $200.40 | 31.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 14 | 18 | $738.00 | $149.22 | 20.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 16 | 17 | $1,088 | $96.22 | 8.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 16 | 17 | $476.00 | $86.36 | 18.1% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 13 | 13 | $208.00 | $66.04 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 276 | $44,712 | $20,169 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 93 | $10,230 | $5,023 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $8,448 | $4,059 | 48.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 128 | 179 | $14,678 | $2,353 | 16.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $2,346 | $2,299 | 98.0% |
About Dr. James Grimes, M.D
Dr. James Grimes, M.D is a Family Medicine healthcare provider based in Warrenton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649262106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Grimes, M.D has received a total of $9,747 in payments from pharmaceutical and medical device companies, with $1,370 received in 2024. These payments were reported across 636 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($9,666).
As a Medicare-enrolled provider, Grimes has provided services to 4,513 Medicare beneficiaries, totaling 6,376 services with total Medicare billing of $195,345. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Warrenton, MO
- Active Since 08/19/2005
- Last Updated 01/26/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1649262106
Products in Payments
- FARXIGA (Drug) $794.85
- BREZTRI (Drug) $447.55
- JARDIANCE (Drug) $443.26
- XARELTO (Drug) $404.23
- Ozempic (Drug) $326.41
- Korlym (Drug) $326.29
- UBRELVY (Drug) $316.21
- SYMBICORT (Drug) $295.22
- VRAYLAR (Drug) $289.26
- TRELEGY ELLIPTA (Drug) $260.41
- QULIPTA (Drug) $232.27
- REXULTI (Drug) $221.07
- Otezla (Drug) $183.18
- TROKENDI XR (Drug) $173.14
- EMGALITY (Drug) $172.07
- Dayvigo (Drug) $164.79
- CHANTIX (Drug) $157.31
- QELBREE (Drug) $144.95
- Kerendia (Drug) $143.14
- LYRICA (Drug) $124.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warrenton
Dr. Michael Lin, M.d, M.D
Family Medicine — Payments: $8,881
David Evans, Md, MD
Family Medicine — Payments: $6,942
Dr. Charles Coyne, M.d, M.D
Family Medicine — Payments: $5,656
Ahmad Babar, M.d, M.D
Family Medicine — Payments: $3,580
Steven Von Elten, Md, MD
Family Medicine — Payments: $3,409
Gregory Golub, Md, MD
Family Medicine — Payments: $2,548